Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Peptides & Research Compounds
4
Posts
4
Users
0
Reactions
424
Views
Topic starter
26/01/2020 6:34 pm
Meta-level question: how do you evaluate evidence for PT-141 when the human data is thin and most trials are small?
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
Injection site reactions are trivial until they are not, and a fresh needling technique removes half of them.
Anyone got a paper worth reading on this rather than a write-up of a paper?
26/01/2020 7:45 pm
Same here.
26/01/2020 7:46 pm
Same here.
26/01/2020 8:48 pm
Stupid question: how do you know whether what is in the vial matches the label at all? How long have you been on PT-141?